. FINANCIAL POSITION ANALYSIS (Cont.) - Property, plant and equipment were 15,260.95 million Baht, increased by 878.72 million Baht mainly from progress of construction including clarified water & total water
the drop in the cost of raw materials of CHPP following the progress of EPC work. However, the proportion of revenue that decreased is larger than the decrease in cost of raw materials, resulting in a
Trade accounts receivable 89,880 54,806,594 94,905,150 Unbilled contract work in progress - 20,206,075 13,723,380 Other receivables 589,266 3,501,872 4,067,767 Short-term loans to related party
1,426,552 1,322,005 10,771,134 Trade accounts receivable 89,880 54,806,594 94,905,150 Unbilled contract work in progress - 20,206,075 13,723,380 Other receivables 589,266 3,501,872 4,067,767 Short-term loans
Trade accounts receivable 89,880 54,806,594 94,905,150 Unbilled contract work in progress - 20,206,075 13,723,380 Other receivables 589,266 3,501,872 4,067,767 Short-term loans to related party
progress of MahaSamutr Villas are 95% completed. In Q2 2018, the Company transferred the ownership of MahaSamutr project totaling of 2 villas and recognized revenues of 101 million Baht. The Company expects
, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the
(minute/s Postpaid Prepaid Blended VOU (GB/data s Postpaid Prepaid Blended Device Penetrat 4G‐handset Fixed Broadban FBB subscri FBB net add FBB ARPU ( 1H17 Snap For 1H17, AIS (excluding IC
% -2.4% Prepaid 113 92 86 -24% -6.5% Blended 138 118 112 -19% -5.1% VOU (GB/data sub/month) Postpaid 14.4 16.6 17.0 18% 2.3% Prepaid 10.3 11.1 13.8 34% 23% Blended 11.4 12.7 14.7 29% 16% Device Penetration
appropriate by Dhipaya Bodin as a joint venture. It will benefit potential shareholders in the medical device and distribution business. The current production and distribution line is Blood Line with a